Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 6/3016% below fair value

$1.40−0.10 (-6.67%)

Close on Nov 12, 2026Market cap $11.73MP/E –Yield –

Femasys ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Femasys's ebitda for the twelve months ending Jun 30, 2026 was -$17.23M. For fiscal 2025 it was -$17.25M. The highest annual figure on record is -$6.25M in fiscal 2020.

Annual ebitda

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$17.25M	–
FY2024	Dec 31, 2024	-$17.49M	–
FY2023	Dec 31, 2023	-$14.02M	–
FY2022	Dec 31, 2022	-$11.04M	–
FY2021	Dec 31, 2021	-$7.75M	–
FY2020	Dec 31, 2020	-$6.25M	–

Quarterly ebitda

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$4.98M	–
Q1 FY2026	Mar 31, 2026	-$4.14M	–
Q4 FY2025	Dec 31, 2025	-$4.54M	–
Q3 FY2025	Sep 30, 2025	-$3.57M	–
Q2 FY2025	Jun 30, 2025	-$3.77M	–
Q1 FY2025	Mar 31, 2025	-$5.38M	–
Q4 FY2024	Dec 31, 2024	-$4.64M	–
Q3 FY2024	Sep 30, 2024	-$5.04M	–
Q2 FY2024	Jun 30, 2024	-$4.41M	–
Q1 FY2024	Mar 31, 2024	-$3.39M	–
Q4 FY2023	Dec 31, 2023	-$4.36M	–
Q3 FY2023	Sep 30, 2023	-$3.96M	–
Q2 FY2023	Jun 30, 2023	-$2.80M	–
Q1 FY2023	Mar 31, 2023	-$2.91M	–
Q4 FY2022	Dec 31, 2022	-$2.87M	–
Q3 FY2022	Sep 30, 2022	-$2.92M	–
Q2 FY2022	Jun 30, 2022	-$2.52M	–
Q1 FY2022	Mar 31, 2022	-$2.74M	–
Q4 FY2021	Dec 31, 2021	-$2.22M	–
Q3 FY2021	Sep 30, 2021	-$2.11M	–
Q2 FY2021	Jun 30, 2021	-$1.75M	–
Q1 FY2021	Mar 31, 2021	-$1.67M	–
Q4 FY2020	Dec 31, 2020	-$1.48M	–
Q3 FY2020	Sep 30, 2020	-$1.40M	–
Q2 FY2020	Jun 30, 2020	-$1.32M	–